- Tumors1000+
- Pathologic Processes1000+
- Cancer1000+
- Pathology969
- Nervous System Diseases959
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors1000+
- Pathologic Processes1000+
- Cancer1000+
- Pathology969
- Nervous System Diseases959
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- EGFR positive
- HER2 positive
- PR positive
- EGFR negative
- PD-L1 negative
- BRAF positive
- KRAS positive
- PR negative
- ER negative
- ALK negative
- ALK positive
- BRCA1 positive
- BRCA2 positive
- CD20 positive
- MET positive
- HLA-A positive
- BRAF negative
- HLA positive
- ROS1 negative
- p16 positive
- MYC positive
- ROS1 positive
- IDH negative
- IDH positive
- PIK3CA positive
- RET positive
- MSI-H positive
- BCL2 positive
- CD19 positive
- HR positive
- PALB2 positive
- dMMR positive
- BCL6 positive
- MET negative
- TP53 positive
- BCR-ABL1 positive
- p16 negative
- ATM positive
- BRCA positive
- HLA negative
- KRAS negative
- MSS positive
- NF1 positive
- NRAS positive
- BRCA1 negative
- HBsAg positive
- HLA-A negative
- PTEN positive
- RB1 negative
- RB1 positive
- RET negative
- TP53 negative
- ctDNA positive
- ANA positive
- BRCA2 negative
- CCND1 positive
- CD30 positive
- HPV negative
- NTRK positive
- T790M positive
- anti-dsDNA positive
- CD5 positive
- CFTR positive
- HPV positive
- HbSS positive
- L858R positive
- MGMT negative
- NTRK negative
- Philadelphia chromosome positive
- RAD51 positive
- RAS negative
- RAS positive
- SMN1 positive
- TTR positive
- dMMR negative
- pMMR positive
- ABCA4 positive
- BRIP1 positive
- CDK12 positive
- CHEK2 positive
- Ex19del positive
- MDM2 positive
- MGMT positive
- MLH1 positive
- MMR positive
- MSH2 positive
- MSH6 positive
- MSI-H negative
- NF2 positive
- NRAS negative
- PMS2 positive
- RAD51C positive
- RF positive
- TROP2 negative
- TROP2 positive
- APP positive
- C5 positive
- CD4 positive
- CDK4 positive
- CHEK1 positive
- CLDN18.2 positive
- COL7A1 positive
- EBV positive
- ER or PR positive
- FANCL positive
- FGFR2 positive
- FMR1 positive
- GRN positive
- HBB positive
- HBV DNA negative
- HR negative
- JAK2 positive
- MSS negative
- PD-1 negative
- PD-1 positive
- PIK3CA negative
- PSEN1 positive
- PSEN2 positive
- PSMA positive
- PTEN negative
- PiZZ positive
- RAD51D positive
- RHO positive
- ZnT8 positive
- anti-Sm positive
- p53 positive
- 11q negative
- 11q positive
- AKT negative
- ALPL positive
- AR positive
- ASXL1 positive
- ApoE ε4 positive
- Aβ1-42 positive
- BAP1 positive
- BARD1 positive
- BCL-2 positive
- BRCA negative
- CCND2 positive
- CCND3 positive
- CD20 negative
- CD22 positive
- CD23 positive
- CD4 count positive
- CDK6 positive
- CEACAM5 positive
- COL1A1 positive
- COL1A2 positive
- DLL3 positive
- DMD positive
- DMPK positive
- EBV DNA positive
- EPCAM positive
- ER/PR positive
- FGFR3 positive
- FLT3 negative
- FLT3 positive
- FOXO1 fusion negative
- FVIII positive
- G719X positive
- GAD positive
- GPC3 positive
- H3 K27M positive
- HBV DNA positive
- HBcAb negative
- HBsAg negative
- HEXA positive
- HEXB positive
- HRAS positive
- HRR negative
- HRRm positive
- HbSC positive
- HbSD positive
- HbSβ0-thalassemia positive
- IA-2 positive
- IAA positive
- IGHV negative
- IGHV positive
- KIT positive
- L861Q positive
- MAGE-A4 positive
- MMR negative
- MSI negative
- MSI positive
- MTAP negative
- MYC negative
- NBN positive
- NPM1 positive
- NY-ESO-1 positive
- PDE6A positive
- PDE6B positive
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PTCH1 positive
- Philadelphia chromosome negative
- RAD54L positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adequate Treatment Washout Period
- Adjuvant Therapy (except reconstruction)
- Alopecia from Prior Treatment
- Alpha Blockers
- Anti-HER2 Therapy
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior chemotherapy for Hodgkin's disease
- At least one prior therapy
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
6500 trials
1
2
3
…50